Updated Jul 16, 2026
Tokman Alexander Y is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Alexander Y. Tokman is the Chief Executive Officer of ENDRA Life Sciences Inc., a company developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for tissue visualization. The SEC filing dated 2026-01-24 lists him as CEO with zero insider purchases or sales in that period and shows a single filing event for ENDRA Life Sciences Inc.
| Role | Insider |
|---|---|
| Notability | 28/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-05 | NDRA | ENDRA Life Sciences Inc. | A — Grant or award | 26.9K | $0.00 | |
| 2026-01-24 | NDRA | ENDRA Life Sciences Inc. | A — Grant or award | 75.0K | $0.00 |
Alexander Y. Tokman is the Chief Executive Officer of ENDRA Life Sciences Inc., a company developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for tissue visualization. The SEC filing dated 2026-01-24 lists him as CEO with zero insider purchases or sales in that period and shows a single filing event for ENDRA Life Sciences Inc.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tokman Alexander Y profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.